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Abstract
Background: Exploring bioactive chemistry requires navigating between structures and data from a variety of
text-based sources. While PubChem currently includes approximately 16 million document-extracted structures
(15 million from patents) the extent of public inter-document and document-to-database links is still well below
any estimated total, especially for journal articles. A major expansion in access to text-entombed chemistry is
enabled by chemicalize.org. This on-line resource can process IUPAC names, SMILES, InChI strings, CAS numbers
and drug names from pasted text, PDFs or URLs to generate structures, calculate properties and launch searches.
Here, we explore its utility for answering questions related to chemical structures in documents and where these
overlap with database records. These aspects are illustrated using a common theme of Dipeptidyl Peptidase 4
(DPPIV) inhibitors.
Results: Full-text open URL sources facilitated the download of over 1400 structures from a DPPIV patent and the
alignment of specific examples with IC50 data. Uploading the SMILES to PubChem revealed extensive linking to
patents and papers, including prior submissions from chemicalize.org as submitting source. A DPPIV medicinal
chemistry paper was completely extracted and structures were aligned to the activity results table, as well as linked to
other documents via PubChem. In both cases, key structures with data were partitioned from common chemistry by
dividing them into individual new PDFs for conversion. Over 500 structures were also extracted from a batch of
PubMed abstracts related to DPPIV inhibition. The drug structures could be stepped through each text occurrence and
included some converted MeSH-only IUPAC names not linked in PubChem. Performing set intersections proved
effective for detecting compounds-in-common between documents and merged extractions.
Conclusion: This work demonstrates the utility of chemicalize.org for the exploration of chemical structure connectivity
between documents and databases, including structure searches in PubChem, InChIKey searches in Google and the
chemicalize.org archive. It has the flexibility to extract text from any internal, external or Web source. It synergizes with
other open tools and the application is undergoing continued development. It should thus facilitate progress in
medicinal chemistry, chemical biology and other bioactive chemistry domains.
Background
The majority of chemical information and related data
generated by biomedical research is specified in text
form [1]. A proportion of these primary reports have
been captured in public and commercial databases that
include a document cross-reference linked to standard
chemical representations [2,3]. Two basic methods are
used to populate chemical databases via text. The first is
expert manual curation (EMC) typically using a chemical
sketcher for input. The second is automated name-to-
structure conversion, also termed chemical named entity
recognition (CNER). A third option, automated conver-
sion of images to structures, has only just begun to con-
tribute to public database entries via SureChemOpen [4].
A number of questions arise in regard to the global cor-
pus of bioactive chemistry represented in text. These in-
clude (a) the total “out there” (b) the number represented
in major public databases and (c) the ratio between source
types. The upper limit for (a) could be the 70 million sub-
stances collated in the CAS commercial database but
there are factors suggesting this exceeds the text-based
corpus [5]. At 47 million, PubChem is not only the largest
open repository but also provides content counts by
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submission types that can be used to answer (b) and
(c) [6]. Patent-extracted structures have four major sources
in PubChem. Three of these use CNER, SureChem
(9.3 million) SCRIPDB (4.0 million) and IBM (2.4 million).
The fourth, Thomson Pharma, is an EMC source (3.8 mil-
lion). The union between these is 15 million. The largest
journal extraction source is ChEMBL, with 0.8 million
structures, and PubMed abstracts have 0.2 million linked
structures. The chemistry capture ratio for patents: papers:
abstracts is therefore approximately 70:4:1, with the union
being 16 million. Even if the 70 million CAS-substances
exceeded the text-specified total, the implication is that
explicit document links for anywhere between 20 and 40
million unique structures are missing from public data-
bases. Paradoxically, because of access constraints, this
shortfall is largest for journal content, since the availability
of full-text from the major patent offices is now largely
complete [7].
Researchers exploring bioactive chemistry thus need
ways of extracting structures from document “tombs”. In
this work we explore the utility of chemicalize.org for
this task [8]. Developed by ChemAxon, this web applica-
tion uses a CNER algorithm and dictionaries to identify
chemical structures in text from names and identifiers.
The value of this lies in addressing practical questions,
the answers to which are important to support decisions
in both academic and commercial R&D settings.
Implementation
The chemicalize.org interface
The operational details of chemicalize.org have been re-
cently reviewed [9]. There is also support material asso-
ciated with the web site, including slide sets, videos and
a technical update blog. A brief introduction is provided
below, staring with the main page (Figure 1).
The application has four principle inputs, text strings, a
sketcher interface, URLs and PDF uploads. For all of these,
chemical entities in the text will be converted if they are
recognized as semantic names, CAS numbers, IUPAC
names, SMILES or InChI strings. The conversions auto-
matically generate the quartet of IUPAC, SMILES, InChI
string and the InChIKey, together with ancillary identifiers.
For a web page or PDF, structures found are displayed as a
ribbon of images at the top of the page. These present the
conversions in order of first occurrence in the document,
accompanied in brackets by the count of occurrences of
that structure within the document, and, if a second
bracket is included, the number of different names that
structure had in the document.
Sources and downloads
Document retrieval is outside the scope of this report
but we can indicate compatible sources that were suc-
cessfully used for the examples. For patents, the two
most consistent in terms of URL performance, text qual-
ity and structure extraction numbers, were Free Patents
Online (FPO) and EPO Espacenet [7,10]. For journal ar-
ticles we used the Open Access subset of European
PubMed Central and PubMed for abstracts. Performance
between operating system and browser alternatives can
be configuration-dependent but this evaluation was done
on a standard Windows 7 machine using Firefox and
Chrome (but note an extension to the Safari browser
can chemicalize.org web pages on-the-fly [11]). Features
of the standard Microsoft Office suite that proved useful
included (a) Notepad for format-stripping and editing
text, (b) the ability to transfer either complete URL con-
tent, or specific sections to Word and save a PDF for up-
load to chemicalize.org, and (c) working across multiple
windows (e.g. a converted URL open in one, cross-
pasting to the chemicalize.org text conversion box in a
second and having the a Google interface in a third).
Conversion success rates in CNER are dependent on text
quality. For this reason, results from the direct processing
of URLs can often be improved by removing confounding
formatting. This can be done by converting text sections
into a fresh PDF or selected individual IUPAC names for
iterative editing via the front page text box. For example,
from a 50,000-word patent URL, just the 5,000-word sec-
tion that encompasses relevant IUPAC names for data-
linked examples can be saved as a PDF that will convert
rapidly and cleanly on upload. The download options have
different utilities. The SDF file can be used as an archive to
generate other formats. Alternatively, SMILES produces
the smallest file size for batch uploads to databases and are
convenient for merging and intersecting result sets from
multiple extractions.
Structure searching
The first questions to answer for extracted structures are
their identity or similarity to other sources. For any indi-
vidual compound the most efficient first-pass is a Google
search with the inner skeleton layer of the InChIKey [12].
This will instantly record which major databases include a
matching record. For similarity searches, the logical order
is chemicalize.org itself, followed by internal, public or
commercial databases. For bulk checking, an identity
search against PubChem will be exemplified here. To en-
hance result interpretation a series of MyNCBI custom fil-
ters were set up for this work. Two of these were unions
for the patent and literature-derived compound records
from sources described in the introduction. Two others
record the total and unique matches to chemicalize.org
(see below). The fourth filter was adapted from the consti-
tutive Rule-of-five parameters astpre-set in PubChem, by
the addition of a 250 to 800 Mw window. This provided a
useful separation of reagents and intermediates from lead-
like compounds exemplified in patents.
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One of the reasons for choosing PubChem for triage is
that structures from the chemicalize.org result archive have
recently been deposited (Source name = chemicalize.org
by ChemAxon) [13]. This provides not only the pre-
computed relationships of each structure to the neighbor
space in PubChem but also the connectivity to all other
PubChem sources and “back out” (via chemicalize.org)
to user-submitted URLs or documents. As of April 2013
the chemicalize.org source was linked to 297,083 com-
pound identifiers (CIDs). Of these, just over 20% were
unique (i.e. the exact structures were not present in other
PubChem sources). The fact that 80% of the structures are
independently supported by other submissions (according
to the CID merging rules) indicates the quality of the
chemicalize.org archive. While users need to be aware that
the presence in PubChem introduces circularity in terms of
structure searches per se, any URLs for the chemicalize.org
source link via the substance identifiers (SIDs) may have
been updated since the deposition date. Thus, not only can
the original links in the chemicalize.org entry (accessed via
the SID) be different to those chosen by a new user but
clicking on any link automatically re-extracts the structures
from that URL.
Batch search in PubChem
For batch searches the PubChem query upload interface
is shown below [14].
By selecting “Structure File” in the interface (Figure 2) a
local SMILES, SDF or InChI file from a document extrac-
tion can first be uploaded via “Preview” which counts the
conversions that conform to the PubChem query input
processing rules. The “Identical Structures” default search
is recommended to avoid hit-expansions that may cause
time-outs. Both the pre-search and post-search filtering
options in PubChem are extensive but selected examples
of the latter are shown below.
Results
To present a coherent and relevant set of extractions from
a potentially wide range of examples we have made three
restrictions. The first is that we have orientated searches
around a specific medicinal chemistry theme of Dipeptidyl
Peptidase 4 (DPPIV) inhibitors [15]. As a declared drug
target for diabetes since 1998, this shows useful specificity
as a document keyword search. This extends forwards to
current drug discovery research, as well as backwards over
many years to patent filings, clinical trials and approved
drugs (e.g. saxyglyptin in Figure 1). This protease target
therefore makes a good example to explore global R&D
activities. The second restriction was to illustrate utility
for just the three key document types of patents, papers
and abstracts. The third was to orientate results towards
answering practical questions that typically arise in the
context of a drug discovery project. A set of these is listed
below. The first six are document-centric while the last
three are structure-centric.
1. Can chemical structures be identified in this
document?
2. How many can be extracted?
3. Which ones have database entries?
4. Which database entries have links to this document?
5. Where in the document are the structures specified?
6. Can SAR data be linked to structures in the
document?
7. What other documents include this structure?
8. Which database records for this structure have links
to other documents?
Figure 1 Home page. The IUPAC name for saxyglyptin (from PubChem CID 11243969) has been pasted in the query box on the left. This has
been processed on the right as indicated by complete dotted underlining. Moving the mouse over this dotted line renders the structure (inset
box on the right) and provides access to a full set of links.
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9. What additional connections can be made using
similarity searches?
In the context of these restrictions we can present a
schematic of the options that can be used in conjunction
with chemicalize.org (Figure 3).
Patent extraction
To answer the initial questions a recently published
DPPIV patent was selected (US20120040982 [16]). The
FPO URL was used to extract the entire document via
the Webpage Viewer (Figure 4).
The question “can chemical structures be identified in
this document” was answered by scrolling through a set
of examples in the description section (Figure 4). After
this qualitative indication of successful conversions, the
second question “how many structures were extracted?”
had already been answered in top-right hand of the display
ribbon as 1414. Scrolling through the web pages indicated
that most IUPAC names had been fully converted. Import-
antly, these included the majority of the structures speci-
fied in the main example section (starting at page 46 in
the patent). The question “which ones have database en-
tries” was answered by a batch upload query described
above (Figure 2). In this way intersects can be generated
for any database(s) but the results for PubChem are shown
in Figure 5.
The question “do any of these have links to this docu-
ment?” was answered for individual records by inspect-
ing sources, for example, CID 57499553 (at the top of
Figure 5) has two. The chemicalize.org entry (SID
137228062) links to the most recent URLs extracted by
users for US20120040982. The SureChemOpen entry (SID
152667195) links to the same document but with 17 add-
itional members of the patent family. The question as to
“where in any document an individual database structure
is located?” is easiest to answer in reverse by establishing
the PubChem match for a chemicalize.org conversion at
a certain position. For a patent there are two alternatives,
following the chemicalize.org ribbon display in sequence
in the document or searching the structure in
SureChemOpen (directly on the SureChem website, or via
the PubChem link). In this case, SID 152667195 was lo-
cated to example 496, but note that structures can be spe-
cified multiple times in a patent.
The question “can SAR data be connected to structures
in the document?” requires the prior location of activity
results. The table on page 13 of the US20120040982 PDF
assigns a DPPIV IC50 of 78 nM to “example 16”. We can
then locate this structure by searching the example num-
ber in the text. There are many options in the properties
display page, from which we have selected three (Figure 6).
The InChIKey was Google-negative but matched CID
57498937 by a direct search in PubChem. This had been
submitted by both SureChem (SID 152666516) and
chemicalize.org (SID 137227422). The result thus pro-
vided an answer to “what other documents include this
structure?” as negative. We then addressed the related
question “which (other) database records have links to
documents?” However, the difficulty associated with this
is the substantial amount of common chemistry typically
extracted along with the examples. The solution in this
case was to prepare a PDF containing only the 38
IUPACs specifically claimed on page 63 of the original
document. This was extracted and the results uploaded
to PubChem, thereby excluding reagents and prior-art
descriptions. This gave 34 CID matches, 32 of which had
both SureChem and chemicalize.org as sources. In
addition, eight of these had ChEMBL as a third source,
thus providing links to journal articles and assay data. For
example, CID 24750280, the eighth structure in the claim
list, had a published IC50 displayed in the PubChem
Figure 2 PubChem Batch Search interface [14].
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record for the inhibition of DPPIV in Caco-2 cells of 88
nM derived from PMID 18052023 [17].
Having made total and sectional extractions from this
document (a moderate size of patent at 65 pages)
benchmarking statistics can be generated (Table 1).
In a typical medicinal chemistry patent it would be diffi-
cult to determine the potentially extractable total (row 1,
column 1) because of extensive redundancy in the form of
repeated exemplifications, reagents, intermediates and
Markush components. Notwithstanding, across the first
row, columns 1 and 2 show 96% of the uploaded SMILES
were verified by the PubChem structure checker. From
columns 3 and 5, we can establish that 96% of the
extracted structures were already in PubChem. The high
SID: CID ratio indicates that these included a substantial
amount of common chemistry or known drug structures
(i.e. each structure having on average 63 submitters) most
of which were already represented in the 1252 chemicalise.
org entries. Inspection of the 52 structures unique to this
source (column 8) shows lead-like structures that were ab-
sent from PubChem. Row 2 provides a direct in-verses-out
assessment from the IUPAC names (497) and the conver-
sions by PubChem (468) with a 94% yield. In this row the
SID: CID ratio drops to 2.1 because most of these lead-like
examples were novel structures from (on average) only two
sources, SureChemOpen and chemicalize.org. The claimed
compounds (row 3) have an 89% conversion. The 30
matching structures in PubChem have more sources be-
cause some of them have been extracted from published
papers (i.e. the SIDs include five ChEMBL entries).
The exploration of chemistry in a patent document can
have different domain-specific utilities but the basic out-
comes can be reviewed. Chemicalize.org has converted the
majority of example structures that circumscribe the sub-
ject matter and enable further analysis. The observation
that most of these were already in PubChem is likely
to be the default case for patents from the major author-
ities, unless they have been published since the latest
Figure 3 Workflow Overview. The diagram covers a representative triage from search to the analysis and storage of results. Note that for
simplicity not all options are shown. (Abbreviations used; Free Patents Online = FPO, Europe Pub Med Central = EPMC).
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SureChemOpen deposition. The extensive matches to
chemicalize.org confirmed, via the links, that a user had
already converted this document (i.e. one of the authors
C.S.). The partitioning of novel structures from common
chemistry was achieved by isolating the example sections.
The SAR-to-structure mapping was discerned by two
routes. The first was intra-document via the data in the
patent (which could easily be extended to complete the
whole table). The second was inter-document connections
to published results for some of the same compounds in
medicinal chemistry journals (via ChEMBL). The option
of sectioning the document provides flexibility, for ex-
ample in being able to separate structures extractable from
the introduction, description, synthetic schema or claims.
Figure 4 A converted section from US20120040982. This shows one of the example series from page 10 in the patent PDF. The details of
“example 16” converted from the IUPAC name are highlighted yellow in the list and linked to the grey bar in the structure display ribbon.
Figure 5 PubChem structure matches for US20120040982 extraction. The screenshot is the result from the batch search upload of 1414
SMILES via extraction of the FPO URL for US20120040982. The display of 1308 matches was ranked by CID number and two exemplified
structures are shown. The counts matching the five MyNCBI filters set up for this work are highlighted in blue (top right corner).
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Extraction from papers
While the questions we can ask are similar to those for pat-
ents, journal papers have the advantages of a smaller docu-
ment size and typically include explicit specification of the
key structures being studied with their bioactivity results.
The example chosen was a DPPIV medicinal chemistry
paper from European PubMed Central (PMC3305890) with
free full text-access published by the company Kenkyusho
in 2006 [18]. The question “how many structures could be
extracted?” was answered as 52 from the PubMed Central
URL. However, the focus of the paper was on just 12 com-
pounds linked to SAR data. Identification of the first ex-
ample (4a) is shown in Figure 7.
The answer to the question “which extractions have
database entries?” was all of them, (i.e. 52 matches in
PubChem). The common chemistry was partitioned by
making a PDF of just the 12 key IUPAC names. The
downloaded structures could then be aligned with the
IC50, clearance and P540 metabolism results (Table 1 in
PMC3305890) thus answering the question “which data
can be connected to which structures in the document?”.
The structure search in PubChem included 12 CID
matches, all of which had chemicalize.org as a source
(here again, this was because the paper had been extrac-
ted during this work). Unusually, 11 were unique to
chemicalize.org since only one CID 10383508; (4a from
Figure 7) had other source links. These thus answered the
question “which database records for this structure have
links to other documents?”. The SureChemOpen entry, via
a same-connectivity link (SID 157613372) established a link
to example 61 in a Kenkyusho patent, WO2004067509
[19]. The ChEMBL entry (SID 103476839) was linked to a
publication (PMID 16392822) where the IC50 inhibitory
activity of this structure against DPPIV was 49 nM [20].
We also used CID 10383508 to answer the question “what
additional connections can be made for a structure using
similarity searches?” in two ways. The first was to launch
“ChemSearch” from the chemicalize.org entry which re-
cords 1934 structures out to a Tanimoto similarity score of
0.5. The second was launching the equivalent search within
PubChem that recorded 632 matches with a similarity score
of 0.85.
Outcomes for this paper extraction included extensive
PubChem matches. In addition, all the key compounds
Figure 6 Selected details from the chemicalize.org display page for “example 16” from US20120040982. The four “Names and identifiers"
are computed. The “Webpages” result is for exact matches in web pages and documents submitted by chemicalize.org users. “Similar Structures”
shows the top results of a similarity search against the chemicalize.org archive (in this case two analogues from the same patent).
Table 1 Extraction, upload and PubChem match statistics for US20120040982
Extraction source Upload Conv. Fail CIDs SID:CID CZ in PC CZ-only
Full-text URL n/a 1414 1364 34 1308 63 1252 52
Main examples (PDF) 497 486 468 0 462 2.1 457 16
Claims-only (PDF) 38 34 34 0 30 3.1 28 0
The row results are derived from; 1) the FPO URL as shown in Figure 5 2) the main example section IUPAC names pasted out of “Description”, saved as a PDF and
subsequently uploaded for document extraction, 3) the IUPAC names in the “Claims” section, similarly saved as a PDF for uploaded . The column results are; 1) the
count of SMILES downloaded from chemicalize.org and subsequently uploaded, 2) successful PubChem conversions, 3) PubChem conversion failures, 4) PubChem
CID exact matches, 5) substance: compound counts (i.e. the average SID: CID ratio), 6) matches in PubChem that included chemicalize.org as one of the CID
sources and 6) with chemicalize.org as the only source.
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were aligned against the SAR table and links to add-
itional relevant documents established. The triaging of
similarity results and their connectivity cannot be ex-
panded on here but note that the 2D and 3D neighbor
spaces in PubChem can be both explored and graphic-
ally clustered for any CID. This extraction also provides
a remediation example. The initial conversion pass for
the synthetic intermediate in section 4.1.2 from Figure 7
in the paper, failed. Copying this out of the manuscript
web page as text string and pasting it into chemicalize.org
corrected this to (2S)-1-(2-chloroacetyl) pyrrolidine-2
-carbonitrile. This was then InChIKey matched via Google
to PubChem CID 11073883 which had 24 sources.
Abstracts
These have the advantage of standardized text “chunks” for
extraction but the disadvantage that only a small propor-
tion of the chemical content of a paper may be specified in
the abstract. This section describes a bulk result set from
PubMed queries. Combining a set of filters (chemistry
journals AND “dpp iv OR dipeptidyl peptidase AND inhibi-
tor [Title/Abstract]” AND the last 10 years) produced 295
abstracts. These were downloaded as MEDLINE format
because this converts more structures from MeSH annota-
tions than selecting just the abstract text. The first question
is “how many structures can be extracted from this
set”. The answer, after conversion to a PDF, was 528 struc-
tures. A converted section from this document is shown
in Figure 8.
The answer to the question “how many have database
matches” is 463 but, because the literature-linked filter
only recorded 374, the chemicalize.org results provide
89 new abstract-to-database links and 154 structures
that are absent in PubChem. Inspection of the ribbon
display shows additional utility where, as expected from
the query, DPPIV drugs are frequently mentioned. Not
only can these be explicitly counted but they can be
“stepped through” to locate each occurrence in a specific
abstract (e.g. each of the 42 mentions of sitaglyptin).
However it should also be noted that Figure 8 includes a
false-positive structure. DPP was recognized as synonym
for di-n-pentylphthalate because of the spacing in the
abstract text (i.e. DPP IV vs. DPPIV).
This analysis indicates useful complementarity with
PubMed where chemicalize.org can recognize (and count)
structures in abstract sets that are either missing from
PubChem or have no direct PubMed-PubChem links.
An example is the MeSH supplementary concept IUPAC
from PMID 20128619 in the abstract set [21]. This novel
DPPIV inhibitor has now become CID 60206521 via the
chemicalize.org-only submission (i.e. added to PubChem
as a consequence of user extraction and includes a link to
the abstract). The simple triage used above (PubMed > re-
sult file > chemicalize.org) can be applied to any slice of
the 22 million MEDLINE abstracts.
Intersecting extractions
The examples above have approached connectivity and
content questions via database searches. However, it is
also important to be able to independently address the
question “what other documents include (or omit) this
structure?” (e.g. compounds-in-common and/or unique
content). This becomes important where the database
matches are only partial for any document. There are
many technical options for performing the requisite set
intersections but the Venny tool provides a useful 4-way
overlap [22]. This is demonstrated by using four of the
DPPIV-related document extractions described above,
namely two patents, one paper and the abstract set. The
Venny result is shown in Figure 9.
Details of these intersects and differences need not be
expanded here, but the combination of chemicalize.org
and Venny allows these to be followed-up. Each subset
can be isolated and checked by PubChem searching and/
or re-extraction. Not only can any combination of extrac-
tions or database lists be used (e.g. SMILES, InChI or even
Figure 7 Extracting the “Methods” section of PMC3305890. The result for 4a is shown as the topmost IUPAC name.
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standardized IUPAC names), but Venny can also merge
and de-duplicate concatenated sets of chemicalize.org out-
puts (e.g. in this case the four sets added up to 2,049
unique SMILES).
Limitations
The ability of chemicalize.org to recognize all structures
specified in a section of text, as well as the potential
addition of false-positives, is subject to the constitutive
limitations of CNER. While some document-specific fai-
lure rates are shown in Table 1, it should also be noted
that IUPAC names not correctly extracted on a first-
pass, can potentially be remediated by simple fixes. One
of these, pasting minimally formatted text blocks into
“clean” PDFs, has already been mentioned. Another is
that common IUPAC name conversion errors (e.g. 1 vs.
L, spaces, line breaks, missing brackets or author errors
in the primary text) can, in many cases, be iteratively
corrected using the front page text input box. False-
positives are mainly derived from split IUPAC names,
homonym clashes (e.g. some gene symbols being identi-
cal to chemical acronyms) unresolvable synonyms (e.g.
the same names being used in the literature to refer to
different structures) and contextual ambiguity (e.g.” x
derivatives” being translated to a structure for “x”).
While the chemicalize. org dictionary is subject to regu-
lar updates and expansions to reduce these limitations,
it should be noted that, in practice, the low level of
false-positives are easily spotted and would not usually
confound further analysis.
Conclusions
The results above demonstrate the value of chemicalize.
org to answer questions related to the chemical content
of the key document types for biomedical research. It
should also be pointed out that the strong growth in
open-access journal content (as PDF and/or URLs) will
expand chemicalization.org options. The approaches
outlined are not only technically straightforward for
those unfamiliar with cheminformatics but they can also
be extended to any text source, including internal docu-
ments and chemical information on the web. The ability
to make reciprocal document-to-document, document-
to-database or document-to-web connectivity is of cru-
cial importance. In addition, the indexing of PubChem
and ChemSpider by Google has become complementary
and transformative because over 50 million aggregated da-
tabases entries (including the chemicalize.org archive) can
now be checked for an InChIKey match [12]. Similarity
searches in databases extend this connectivity even further.
In regard to connectivity, the absolute correctness and
completeness extraction of any document extraction per
se is less important than the ability to make joins using
just a sample of the important extracted structures. For
example, there is high value in establishing that patent
A, journal article B, PubMed abstract C and database
record D, are, from the bioactivity standpoint, probably
referring to the same canonical chemical entity. This
means that the associated data can be merged between
documents, regardless of salt form or isomer differences.
Figure 8 Result section from a bulk abstract extraction. The upper part of the figure is a section of the structure display ribbon in order of
occurrence in the PDF. Saxaglyptin is highlighted (yellow) from the abstract text for PMID 22651127 (Preclinical development of dipeptidyl
peptidase IV inhibitor alogliptin). Recognized chemical terms underlined in text are linked to structures in the ribbon, five of which are shown.
Figure 9 Venn intersects from extracted documents. The SMILES
input totals (left to right) were 285 for the Kenkyusho patent
WO200406750, 52 for the Kenkyusho paper PMC3305890, 1414 for
the Boehringer patent US2012004098 and 512 for the DPPIV
abstract set.
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In the case of boutique sources that either cross-
reference thinly or not at all, chemicalize.org may be the
only way to make such joins. There are also synergies
with other open tools (in addition to Venny). These in-
clude OPSIN for IUPAC names [23], OSRA for chemical
images [24] and Utopia for bio-entity recognition [25].
The performance and scope of chemicalize.org is being
continually developed, including implementation for
mobile phones [26]. It is therefore destined to make an
increasing impact in medicinal chemistry, chemical biol-
ogy and other bioactive chemistry domains.
Availability and requirements
The application is publicly available for on-line use at
chemicalize.org and can be accessed with any modern web
browser. There is also a free Android mobile app. The core
underlying functionality is available as the ChemAxon's
“Naming” commercial product suite that includes the
chemical name conversion and mining engine. Use of
these products on chemicalize.org is covered by Creative
Commons BY-NC-SA 3.0 license.
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